Overall, these findings prompted us to look into the relationship between miRNA-495 and clinical characteristics like menopause, lymph node, ER, PR, HER2, TNM stages, and metastasis in large clinical samples of BC. This evidence concerns the gene ERBB2 and breast cancer.